Clinical Trials/TCTR20210616003

TCTR20210616003

Not yet recruiting

Not Applicable

Coronary Artery Disease Acute Coronary Syndrome Myocardial Infarction Percutaneous Coronary Intervention

Faculty of Medicine, Chiang Mai University0 sites2,000 target enrollmentJune 16, 2021

Conditionschronic coronary syndromeacute coronary syndromemyocardial infarction with non-obstructive coronary arteryheart failure Coronary Artery Disease Acute Coronary Syndrome Myocardial Infarction Percutaneous Coronary Intervention

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: chronic coronary syndromeacute coronary syndromemyocardial infarction with non-obstructive coronary arteryheart failure
Sponsor: Faculty of Medicine, Chiang Mai University
Enrollment: 2000
Status: Not yet recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

June 16, 2021

End Date

June 30, 2025

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Faculty of Medicine, Chiang Mai University

Eligibility Criteria

Inclusion Criteria

•all patients undergoing percutaneous coronary intervention (PCI) at Maharaj Nakorn Chiang Mai Hospital.

Exclusion Criteria

•patient not undergoing percutaneous coronary intervention (PCI)

Outcomes

Primary Outcomes

Not specified

Similar Trials

The Australian COPS trial - COlchicine in Patients with acute coronary SyndromesIschaemic heart diseaseCardiovascular - Coronary heart disease

ACTRN12615000861550St. Vincent's Hospital Melbourne800

Active, not recruiting

Acute heart failure in acute coronary syndrome: Double blind comparison of levosimendan and placebo - LEVI´SAcute coronary syndrome treated with percutaneous coronary intervention (PCI)Patients suffering from acute heart failure after the procedure will be randomised to the studyMedDRA version: 9.1Level: LLTClassification code 10000803Term: Acute heart failure

EUCTR2008-001637-10-FIHUCH, Division of Cardiology

Clinical Pathways for Acute Coronary Syndromes in China - phase 2: implementation and evaluatioAcute Coronary SyndromesCardiovascular - Coronary heart disease

ACTRN12609000491268Sanofi-Aventis (China)15,000

Atherosclerotic Complex coronary Artery Diseases treated by Zotarolimus-Eluting Resolute Onyx stent ~A multi-center registry~

JPRN-UMIN000038451Toyohashi Heart Center800

Mie Acute Coronary Syndrome RegistryAcute Coronary Syndrome

JPRN-UMIN000036020Mie University Hospital, CCU Network Center6,000